drug discovery
Sophia Genetics Partners With MSK on Clinical Decision Support, Boundless Bio on ecDNA Detection
Sophia will provide Memorial Sloan Kettering with predictive tumor analysis technology and help startup Boundless develop new therapies and MDx methods.
MultiOmic Health, Mesh Bio Partner to Study Chronic Metabolic Disease for Drug, Dx Development
The companies will build a diverse research cohort with multiomics data and apply AI as they seek to improve diagnostics and advance drug discovery.
Illumina, Janssen Biotech Form Strategic Partnership to Develop Precision Medicines
The collaboration aims to utilize the sequencing giant's data analytics platforms and lab services to speed up the development of personalized therapies.
Kiyatec Raises $3M in Series B2 Funding Round
The firm will use the proceeds to further a validation study tracking the ability of its cell culture assay to predict patient response to cancer therapies.
Alexion, Sema4 Partner to Improve Diagnosis of Rare Diseases
The companies will share bioinformatics and NGS expertise to speed the identification of diseases, accelerate drug discovery, and find "genomic shields."